CGEM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.82%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,727,655.68

Cullinan Oncology Insider Trading History Chart

Cullinan Oncology Share Price & Price History

^$25.30

▲ +6.05 (31.43%)

As of 04/26/2024 05:00 PM ET

Days: 30 | 90 | 365

Move Your Money Before May 1

From Stansberry Research | Ad

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1.

Cullinan Oncology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2024	Corrine Savill	Insider	Sell	40,000	$16.18	$647,200.00	165,990
1/29/2024	Corrine Savill	Insider	Sell	40,000	$14.09	$563,600.00	165,990
1/22/2024	Corrine Savill	Insider	Sell	18,684	$12.14	$226,823.76	165,990
12/26/2023	Nadim Ahmed	CEO	Sell	4,272	$9.24	$39,473.28	111,550
12/21/2023	Jeffrey Alan Jones	Insider	Sell	1,860	$8.50	$15,810.00	56,191
12/21/2023	Jeffrey Trigilio	CFO	Sell	1,920	$8.50	$16,320.00	83,919
12/18/2023	Jeffrey Alan Jones	Insider	Sell	386	$8.22	$3,172.92	58,051
12/18/2023	Jeffrey Trigilio	CFO	Sell	398	$8.22	$3,271.56	85,839
12/12/2023	Jeffrey Trigilio	CFO	Sell	1,926	$7.81	$15,042.06	86,237
12/12/2023	Jennifer Michaelson	Insider	Sell	1,068	$7.81	$8,341.08	88,965
6/28/2023	Nadim Ahmed	CEO	Sell	759	$11.40	$8,652.60	115,822
6/20/2023	Jeffrey Alan Jones	Insider	Sell	387	$12.94	$5,007.78	58,437
6/20/2023	Jeffrey Trigilio	CFO	Sell	399	$12.94	$5,163.06	85,823
6/12/2023	Jeffrey Trigilio	CFO	Sell	319	$13.11	$4,182.09	86,222
6/12/2023	Jennifer Michaelson	Insider	Sell	176	$13.11	$2,307.36	90,271
6/6/2023	Jennifer Michaelson	Insider	Sell	11,900	$12.31	$146,489.00	90,447
5/23/2023	Nadim Ahmed	CEO	Sell	707	$9.15	$6,469.05	116,581
5/18/2023	Jeffrey Trigilio	CFO	Sell	399	$8.76	$3,495.24	86,541
5/18/2023	Jennifer Michaelson	Insider	Sell	239	$8.76	$2,093.64	90,447
5/12/2023	Jeffrey Trigilio	CFO	Sell	347	$8.78	$3,046.66	86,940
5/12/2023	Jennifer Michaelson	Insider	Sell	193	$8.78	$1,694.54	90,686
4/25/2023	Nadim Ahmed	CEO	Sell	716	$10.59	$7,582.44	117,288
4/18/2023	Jeffrey Alan Jones	Insider	Sell	392	$10.71	$4,198.32	59,218
4/18/2023	Jeffrey Trigilio	CFO	Sell	398	$10.71	$4,262.58	87,287
4/12/2023	Jeffrey Trigilio	CFO	Sell	318	$10.22	$3,249.96	87,685
4/12/2023	Jennifer Michaelson	Insider	Sell	176	$10.22	$1,798.72	91,117
3/23/2023	Nadim Ahmed	CEO	Sell	706	$10.51	$7,420.06	118,004
3/20/2023	Jeffrey Alan Jones	Insider	Sell	390	$11.32	$4,414.80	59,610
3/20/2023	Jeffrey Trigilio	CFO	Sell	399	$11.32	$4,516.68	88,003
11/25/2022	Jennifer Michaelson	Insider	Sell	4,000	$13.30	$53,200.00	53,031
9/27/2022	Jennifer Michaelson	Insider	Sell	4,000	$12.40	$49,600.00	53,031
8/4/2022	Vision Scs F2	Major Shareholder	Sell	25,989	$14.31	$371,902.59	1,255,963
8/2/2022	Vision Scs F2	Major Shareholder	Sell	4,792	$14.10	$67,567.20	1,301,081
7/25/2022	Jennifer Michaelson	Insider	Sell	8,000	$14.51	$116,080.00	53,031
7/18/2022	Corrine Savill	Insider	Sell	5,042	$15.06	$75,932.52	164,573
7/11/2022	Corrine Savill	Insider	Sell	40,000	$13.33	$533,200.00	169,615
6/23/2022	Bioscience I 2017 Ltd F2	Major Shareholder	Sell	29,631	$13.00	$385,203.00	537,392
6/21/2022	Bioscience I 2017 Ltd F2	Major Shareholder	Sell	22,319	$12.77	$285,013.63	616,976
6/6/2022	Nadim Ahmed	CEO	Buy	8,090	$12.40	$100,316.00	8,090
6/1/2022	Bvf Partners L P/Il	Major Shareholder	Buy	751,396	$11.00	$8,265,356.00	4,058,854
5/16/2022	Vision Scs F2	Major Shareholder	Sell	35,158	$11.23	$394,824.34	1,305,873
5/12/2022	Vision Scs F2	Major Shareholder	Sell	264,072	$9.25	$2,442,666.00	1,460,539
4/1/2022	Bvf Partners L P/Il	Major Shareholder	Buy	276,000	$10.75	$2,967,000.00	301,671
10/18/2021	Jennifer Michaelson	Insider	Sell	4,000	$21.42	$85,680.00
10/15/2021	Jeffrey Trigilio	CFO	Sell	8,000	$25.00	$200,000.00
10/15/2021	Leigh Zawel	Insider	Sell	19,574	$25.00	$489,350.00
10/7/2021	Leigh Zawel	Insider	Sell	1,079	$25.00	$26,975.00
9/20/2021	Jennifer Michaelson	Insider	Sell	4,000	$24.51	$98,040.00
9/15/2021	Ansbert Gadicke	Director	Sell	888	$29.16	$25,894.08
9/15/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	6,425	$29.16	$187,353.00
9/13/2021	Ansbert Gadicke	Director	Sell	497	$29.10	$14,462.70	248,170
9/13/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	3,595	$29.10	$104,614.50	248,170
9/9/2021	Ansbert Gadicke	Director	Sell	1,898	$29.35	$55,706.30
9/9/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	13,727	$29.35	$402,887.45	248,170
9/7/2021	Ansbert Gadicke	Director	Sell	3,465	$29.04	$100,623.60	255,032
9/7/2021	Leigh Zawel	Insider	Sell	28,118	$28.95	$814,016.10
9/7/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	25,067	$29.04	$727,945.68
9/3/2021	Ansbert Gadicke	Director	Sell	1,760	$29.60	$52,096.00	255,032
9/3/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	12,731	$29.60	$376,837.60	255,032
9/1/2021	Ansbert Gadicke	Director	Sell	790	$29.47	$23,281.30	259,975
9/1/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	5,714	$29.47	$168,391.58	259,975
8/30/2021	Ansbert Gadicke	Director	Sell	4,285	$29.30	$125,550.50	264,437
8/30/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	31,001	$29.30	$908,329.30
8/27/2021	Ansbert Gadicke	Director	Sell	1,846	$29.09	$53,700.14	264,437
8/27/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	13,357	$29.09	$388,555.13
8/25/2021	Ansbert Gadicke	Director	Sell	237	$29.09	$6,894.33
8/25/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	1,713	$29.09	$49,831.17
8/23/2021	Ansbert Gadicke	Director	Sell	7,376	$29.11	$214,715.36
8/23/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	53,359	$29.11	$1,553,280.49	273,545
8/11/2021	Ansbert Gadicke	Director	Sell	347	$29.05	$10,080.35	280,921
8/11/2021	Oncology Impact Fund L.P. Ubs	Major Shareholder	Sell	2,510	$29.05	$72,915.50
8/9/2021	Leigh Zawel	Insider	Sell	21,204	$26.57	$563,390.28

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

SEC Filings (Institutional Ownership Changes) for Cullinan Oncology (NASDAQ:CGEM)

86.31% of Cullinan Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cullinan Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2024	American International Group Inc.	1,236,564	$12.60M	0.1%	+0.1%	2.891%
2/15/2024	Parkman Healthcare Partners LLC	529,877	$5.40M	0.8%	+20.8%	1.239%
2/14/2024	Braidwell LP	1,240,865	$12.64M	0.5%	-35.0%	2.901%
2/13/2024	American International Group Inc.	1,236,564	$12.60M	0.1%	+0.1%	2.891%
2/13/2024	Tower Research Capital LLC TRC	10,234	$0.10M	0.0%	-33.5%	0.024%
2/13/2024	Affinity Asset Advisors LLC	300,000	$3.06M	0.6%	N/A	0.701%
2/13/2024	NEOS Investment Management LLC	15,906	$0.16M	0.0%	N/A	0.037%
2/9/2024	Franklin Resources Inc.	3,281,280	$33.44M	0.0%	+13.5%	7.670%
2/9/2024	Quest Partners LLC	17,601	$0.18M	0.0%	N/A	0.041%
2/9/2024	Trexquant Investment LP	34,955	$0.36M	0.0%	N/A	0.082%
2/6/2024	Swiss National Bank	46,300	$0.47M	0.0%	+19.9%	0.108%
2/6/2024	New York Life Investment Management LLC	33,759	$0.34M	0.0%	-3.0%	0.079%
2/2/2024	Bailard Inc.	10,800	$0.11M	0.0%	N/A	0.025%
1/30/2024	Vontobel Holding Ltd.	10,000	$0.10M	0.0%	N/A	0.023%
1/24/2024	China Universal Asset Management Co. Ltd.	4,954	$50K	0.0%	+352.4%	0.012%
1/12/2024	SG Americas Securities LLC	14,449	$0.15M	0.0%	+12.3%	0.034%
1/5/2024	Exchange Traded Concepts LLC	14,076	$0.14M	0.0%	+34.0%	0.033%
12/6/2023	Citigroup Inc.	23,534	$0.21M	0.0%	+186.1%	0.055%
11/15/2023	Annandale Capital LLC	12,000	$0.11M	0.0%	+20.0%	0.028%
11/15/2023	Kennedy Capital Management LLC	489,446	$4.43M	0.1%	-9.7%	1.144%
11/14/2023	Schonfeld Strategic Advisors LLC	121,800	$1.10M	0.0%	+15.9%	0.285%
11/13/2023	Algert Global LLC	16,540	$0.15M	0.0%	N/A	0.039%
11/13/2023	Federated Hermes Inc.	20,000	$0.18M	0.0%	N/A	0.047%
11/13/2023	Hsbc Holdings PLC	21,875	$0.20M	0.0%	N/A	0.051%
11/8/2023	New York Life Investment Management LLC	34,804	$0.32M	0.0%	-13.6%	0.081%
11/7/2023	Barclays PLC	53,393	$0.48M	0.0%	+145.6%	0.125%
11/6/2023	Assenagon Asset Management S.A.	609,106	$5.51M	0.0%	+380.1%	1.425%
10/27/2023	Allspring Global Investments Holdings LLC	7,095	$64K	0.0%	-61.6%	0.017%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	6,542	$59K	0.0%	+1,331.5%	0.015%
10/24/2023	Bank of New York Mellon Corp	97,159	$0.88M	0.0%	+11.5%	0.227%
10/20/2023	Harbor Capital Advisors Inc.	10,266	$93K	0.0%	-26.1%	0.024%
10/18/2023	Exchange Traded Concepts LLC	10,507	$95K	0.0%	-9.9%	0.025%
10/13/2023	SG Americas Securities LLC	12,862	$0.12M	0.0%	N/A	0.030%
8/22/2023	CHI Advisors LLC	3,414,189	$36.74M	11.1%	+1.9%	7.988%
8/15/2023	Braidwell LP	1,908,865	$20.54M	0.7%	N/A	4.466%
8/11/2023	SVB Financial Group	13,516	$0.15M	0.3%	-33.3%	0.034%
8/11/2023	Velan Capital Investment Management LP	50,000	$0.54M	0.5%	N/A	0.127%
8/11/2023	Franklin Resources Inc.	2,334,086	$25.12M	0.0%	+195.8%	5.930%
8/11/2023	ExodusPoint Capital Management LP	39,161	$0.42M	0.0%	-11.3%	0.099%
8/7/2023	New York Life Investment Management LLC	40,287	$0.43M	0.0%	-8.2%	0.102%
8/4/2023	American International Group Inc.	1,235,169	$13.29M	0.1%	-0.1%	3.138%
8/2/2023	Bank of Montreal Can	187,547	$2.48M	0.0%	N/A	0.476%
7/25/2023	Assenagon Asset Management S.A.	126,872	$1.37M	0.0%	-42.7%	0.322%
7/24/2023	Allspring Global Investments Holdings LLC	18,470	$0.20M	0.0%	+31.2%	0.047%
7/20/2023	Exchange Traded Concepts LLC	11,661	$0.13M	0.0%	N/A	0.030%
7/18/2023	Allspring Global Investments Holdings LLC	18,470	$0.20M	0.0%	+31.2%	0.047%
7/11/2023	Harbor Capital Advisors Inc.	13,894	$0.15M	0.0%	N/A	0.035%
5/16/2023	BVF Inc. IL	3,196,701	$32.70M	1.2%	-57.4%	8.125%
5/15/2023	EcoR1 Capital LLC	246,410	$2.52M	0.1%	-76.2%	0.626%
5/15/2023	Atom Investors LP	120,109	$1.23M	0.7%	+12.0%	0.305%
5/11/2023	CHI Advisors LLC	3,349,460	$34.27M	9.1%	+1.0%	8.514%
5/8/2023	New York Life Investment Management LLC	43,905	$0.45M	0.0%	N/A	0.112%
5/8/2023	Bailard Inc.	11,000	$0.11M	0.0%	N/A	0.028%
5/2/2023	Amalgamated Bank	2,885	$30K	0.0%	-25.5%	0.007%
5/1/2023	CM Wealth Advisors LLC	14,775	$0.15M	0.0%	N/A	0.038%
4/28/2023	SG Americas Securities LLC	11,066	$0.11M	0.0%	-8.8%	0.028%
4/18/2023	Assenagon Asset Management S.A.	221,340	$2.26M	0.0%	+166.6%	0.563%
4/13/2023	Allspring Global Investments Holdings LLC	14,076	$0.14M	0.0%	+64.6%	0.036%
3/23/2023	MetLife Investment Management LLC	16,425	$0.17M	0.0%	-17.4%	0.042%
2/15/2023	Tang Capital Management LLC	809,231	$8.54M	1.2%	+29.7%	1.774%
2/15/2023	Atom Investors LP	107,193	$1.13M	0.6%	+32.5%	0.235%
2/14/2023	EcoR1 Capital LLC	1,035,038	$10.92M	0.3%	-9.5%	2.269%
2/13/2023	Martingale Asset Management L P	41,629	$0.44M	0.0%	+34.2%	0.091%
2/10/2023	Franklin Resources Inc.	782,126	$8.25M	0.0%	-0.4%	1.715%
2/8/2023	Swiss National Bank	33,000	$0.35M	0.0%	+6.8%	0.072%
2/7/2023	Fox Run Management L.L.C.	10,412	$0.11M	0.0%	N/A	0.023%
2/2/2023	SG Americas Securities LLC	12,137	$0.13M	0.0%	+8.5%	0.027%
2/2/2023	Nisa Investment Advisors LLC	13,900	$0.15M	0.0%	-19.4%	0.030%
1/12/2023	Assenagon Asset Management S.A.	83,010	$0.88M	0.0%	N/A	0.182%
11/28/2022	Birchview Capital LP	25,114	$0.32M	0.2%	-44.3%	0.055%
11/15/2022	Tang Capital Management LLC	624,016	$8M	1.0%	+2.4%	1.368%
11/15/2022	Martingale Asset Management L P	31,016	$0.40M	0.0%	N/A	0.068%
11/15/2022	EcoR1 Capital LLC	1,143,218	$14.66M	0.4%	-2.3%	2.507%
11/14/2022	Annandale Capital LLC	10,000	$0.13M	0.0%	N/A	0.022%
11/14/2022	Baupost Group LLC MA	429,646	$5.51M	0.1%	-72.0%	0.942%
11/14/2022	Rubric Capital Management LP	559,737	$7.18M	0.4%	+88.2%	1.227%
11/14/2022	MetLife Investment Management LLC	19,889	$0.26M	0.0%	+29.2%	0.044%
11/14/2022	Hsbc Holdings PLC	15,283	$0.20M	0.0%	N/A	0.034%
11/9/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,718	$48K	0.0%	N/A	0.008%
11/8/2022	Atom Investors LP	80,871	$1.04M	0.4%	-16.5%	0.177%
11/8/2022	New York State Common Retirement Fund	23,063	$0.30M	0.0%	+31.2%	0.051%
11/7/2022	Nisa Investment Advisors LLC	17,241	$0.22M	0.0%	+24.0%	0.038%
11/7/2022	Birchview Capital LP	25,114	$0.32M	0.2%	-44.3%	0.055%
11/7/2022	Jump Financial LLC	21,700	$0.28M	0.0%	-48.8%	0.048%
11/3/2022	Barclays PLC	8,994	$0.12M	0.0%	+23.8%	0.020%
11/2/2022	Victory Capital Management Inc.	41,980	$0.54M	0.0%	N/A	0.092%
10/31/2022	SG Americas Securities LLC	11,188	$0.14M	0.0%	-11.3%	0.025%
10/28/2022	Silverarc Capital Management LLC	224,555	$2.88M	1.0%	+5.4%	0.492%
10/26/2022	Allspring Global Investments Holdings LLC	8,765	$0.11M	0.0%	-10.2%	0.019%
8/16/2022	Woodline Partners LP	818,572	$10.49M	0.2%	+72.3%	1.795%
8/13/2022	American International Group Inc.	1,237,668	$15.87M	0.1%	+0.1%	2.764%
8/12/2022	Virtus ETF Advisers LLC	8,620	$0.11M	0.0%	-13.3%	0.019%
8/12/2022	Franklin Resources Inc.	779,082	$9.99M	0.0%	+0.2%	1.740%
8/11/2022	Trexquant Investment LP	31,851	$0.41M	0.0%	N/A	0.071%
8/11/2022	Alps Advisors Inc.	26,565	$0.34M	0.0%	N/A	0.059%
8/10/2022	Kennedy Capital Management Inc.	34,347	$0.44M	0.0%	N/A	0.077%
8/9/2022	Swiss National Bank	30,900	$0.40M	0.0%	-14.6%	0.069%
8/3/2022	Nisa Investment Advisors LLC	13,900	$0.18M	0.0%	N/A	0.031%
7/29/2022	SG Americas Securities LLC	12,608	$0.16M	0.0%	N/A	0.028%
7/25/2022	Silverarc Capital Management LLC	213,090	$2.73M	0.8%	N/A	0.476%

Data available starting January 2016

Cullinan Oncology, Inc., a biopharmaceutical company, focuses on developing oncology therapies for cancer patients in the United States. The company's lead program comprises CLN-619, a monoclonal antibody that is in Phase I clinical trial for the treatment of solid tumors. Its development portfolio also includes CLN-049, a humanized bispecific antibody that is in Phase I clinical trial for the treatment of acute myeloid leukemia or myelodysplastic syndrome; CLN-418, a human bispecific immune activator that is in Phase 1 clinical trial for the treatment of multiple solid tumors; and Zipalertinib, a bioavailable small-molecule for treating patients with non-small cell lung cancer. In addition, the company's development products comprise CLN-617, a fusion protein for the treatment of solid tumors; and CLN-978, a T cell engaging antibody for the treatment relapsed/refractory B-cell non-Hodgkin lymphoma. It has license and collaboration agreement with Adimab, LLC to discover and/or optimize antibodies; Harbour BioMed US Inc. for the development, manufacturing, and commercialization of CLN-418; and co-development agreement with Taiho Pharmaceutical Co., Ltd to develop Zipalertinib. Cullinan Oncology, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $25.30

$19.27

$25.72

50 Day Range

MA: $17.18

$15.32

$19.25

52 Week Range

Now: $25.30

$7.64

$25.72

Volume

4,735,577 shs

Average Volume

553,849 shs

Market Capitalization

$1.09 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.33

Who are the company insiders with the largest holdings of Cullinan Oncology?: Cullinan Oncology's top insider investors include:
Bvf Partners L P/Il (Major Shareholder)
Vision Scs F2 (Major Shareholder)
Bioscience I 2017 Ltd F2 (Major Shareholder)
Corrine Savill (Insider)
Nadim Ahmed (CEO)
Jennifer Michaelson (Insider)
Jeffrey Trigilio (CFO)
Jeffrey Alan Jones (Insider)
Learn More about top insider investors at Cullinan Oncology.